Yuyu to launch Uclid tablets

Published: 2008-04-16 06:57:00
Updated: 2008-04-16 06:57:00
Yuyu Pharm received marketing approval from the Korean Food and Drug Administration (KFDA) for Uclid, a combination of ticlopidine HCl and ginkgo biloba extract.

Uclid will be marketed in June in 80 mg tablet strength.

It took 10 years to develop Uclid since the company initiated its study,...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.